TKM.CA Profile & Description — Tekmira Pharmaceuticals Corp
Tekmira Pharmaceuticals is a biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer and other diseases through the development of broad technology platforms. The first platform encapsulates small molecule drugs, such as chemotherapy drugs, in Co.'s proprietary sphingosomal drug delivery system. Co.'s second platform is a proprietary lipid-based technology for the delivery of novel drugs called oligonucleotides to treat diseases by either (a) stimulating the immune system or (b) through a process known as RNA interference, which prevents the production of proteins that are linked to diseases.